Skip to Content

Anthrasil Approval History

  • FDA approved: Yes (First approved March 24th, 2015)
  • Brand name: Anthrasil
  • Generic name: Anthrax Immune Globulin Intravenous (Human)
  • Dosage form: Injection
  • Company: Cangene Corporation
  • Treatment for: Anthrax

Anthrasil [Anthrax Immune Globulin Intravenous (Human)] is an immune globulin used to treat patients with inhalational anthrax in combination with appropriate antibacterial drugs.

Development History and FDA Approval Process for Anthrasil

Mar 25, 2015Approval FDA Approves Anthrasil, [Anthrax Immune Globulin Intravenous (Human)], for Inhalation Anthrax

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.